Table 1.
Name | D | C | E | c | e | hrS | hrB | V/VS† | STEM | DAK | RHD* | RHCE* | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SA | NY | ||||||||||||
RHCE*ceBI and STEM+ | |||||||||||||
Stemper | + | 0 | + | + | +/0 | 0 | + | 0 | + | + | +S |
DOL2
D |
ceBI
cE |
MA72-09 | + | 0 | + | + | +/0 | 0 | + | NT | NT | + | +S |
DOL1
DFV |
ceBI
cE |
RFA-221 | + | 0 | 0 | + | + | +W | + | 0 | NT | + | +S |
DOL2
DAU-0 |
ceBI
ce 48C |
MA170-09 | +/0 | 0 | 0 | + | NT | NT | NT | NT | NT | + | NT |
DOL2
Hemizygous presumed |
ceBI
ce 48C |
J Allen | + | 0 | 0 | + | + | NT | NT | 0 | NT | + | + |
DOL1
D |
ceBI
ceJAL |
MA372-09
RFLP only |
+ | NT | 0 | + | + | NT | NT | + | NT | + | + |
DOL1
Hemizygous presumed |
ceBI
ceS |
RH*CEceBI and STEM
NT | |||||||||||||
MG303-00
RFLP only |
+/0 | 0 | 0 | + | + | NT | NT | 0 | NT | NT | + |
DOL1
Hemizygous |
ceBI
ce |
RFA-075 | + | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT |
DOL1
DIIIa-CE(4-6)-D |
ceBI
ceS |
PC73
RFLP only |
+ | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT |
DOL1
D |
ce818C/T |
LC donor
RFLP only |
+ | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT |
DOL1
D |
ce818C/T |
RHCE*ceSM and
STEM+ | |||||||||||||
Delia
RFLP only |
+ | 0 | 0 | + | + | 0 | NT | 0 | + | + | + |
DOL1
DAU-0 |
ceSM
ceJAL |
Keys | + | 0 | 0 | + | + | 0 | + | 0 | + | NT | + |
DOL1
D |
ceSM
ceJAL |
Hector | + | 0 | 0 | + | + | NT | NT | NT | + | NT | + |
DOL1
DAU-0 |
ceSM
ceMO |
John | +W | 0 | 0 | + | + | NT | NT | + | + | NT | + |
DOL1
Weak D type 4.2.2 |
ceSM
ceAR |
Jack | +w | 0 | 0 | + | + | 0 | + | + | + | + | + |
DOL1
Weak D type 4.2.2 |
ceSM
ceAR |
KHV
RFLP only |
+ | 0 | 0 | + | + | 0 | + | NT | + | NT | + |
DIIIa
D |
ceSM
ceEK |
Dennis | + | 0 | 0 | + | + | 0 | + | +/0 | +W | + | +W |
Weak D type 4.2.2
D186T (novel) |
ceSM
ceAR |
Sybil | + | 0 | 0 | + | + | 0 | + | +/0 | +W | + | +W |
Weak D type 4.2.2
D186T (novel) |
ceSM
ceAR |
STEM+ but not
RHCE*ceBI or RHCE*ceSM | |||||||||||||
Roman | + | 0 | 0 | + | + | +/0 | 0 | +V− |
^ +W |
+W | +S |
DIIIa
DIIIa |
ceS
ce 48C, 733G |
Alson | + | 0 | 0 | + | + | NT | NT | V− | +W | NT | + |
DIIIa, 150C (novel)
DIIIa, 150C (novel) |
ceS
ceS |
STEM− and not
RHCE*ceBI or RHCE*ceSM | |||||||||||||
MA127-08 | + | +W | 0 | 0 | +W | + | 0 | 0 | NT | 0 | + |
D
D |
CeRN
CeRN |
MA315-09 | + | 0 | 0 | + | + | NT | 0 | NT | 0 | NT | + |
DIIIa
DIIIa |
ceS
ceS |
MA156-08 | + | 0 | 0 | + | + | +W | 0 | + | 0 | NT | + |
DIIIa
DIIIa |
ceS
ceS |
E. Dlamini | 0 | + | 0 | + | + | + | 0 | + | 0^^ | 0 | 0 |
DIIIa–CE[4-7]–D
DIIIa–CE[4-7]–D |
ceS
ceS |
M. Shaba | 0 | + | 0 | + | + | + | 0 | + | 0 | NT | 0 |
DIIIa-CE[4-7]-D
DIIIa-CE[4-7]-D |
ceS
ceS |
MA314-09 | 0 | + | 0 | + | + | + | 0 | + | 0 | 0 | 0 |
DIIIa-CE[4-7]-D
DIIIa-CE[4-7]-D |
ceS
ceS |
Marcus | +w | 0 | 0 | + | + | + | 0 | + | 0 | 0 | +W |
DIIIb (DIII type 7)
DIIIb (DIII type 7) |
ceS
ceS |
Norma | +W | 0 | 0 | + | + | 0 | + | + | 0^^ | NT | NT |
Weak D type 4.2.2
Weak D type 4.2.2 |
ceAR
ceAR |
MA318-09
RFLP only |
+ | + | + | + | + | 0 | + | + | 0 | 0 | NT | Not analyzed | Not ceBI or ceSM |
MA149-09 | + | 0 | 0 | + | + | NT | + | + | NT | 0 | +W |
Weak partial D type 4.0 Homo or hemizygous |
ce 48C, 733G Not ceBI or ceSM Hybrid under investigation |
CO 06-11 | 0 | + | 0 | + | + | NT | NT | + | 0^^ | NT | 0 |
Not DOL1 or DOL2 Hybrid under investigation |
ceS
ce |
= positive with a reagent containing anti-V and anti-VS
= not available for repeat testing
originally thought to be STEM+
RFLP = only PCR RFLP assays were performed. Full sequencing was done on the other samples.
NT = not tested